Meta-Analysis: Smoking and Proverty as Risk Factors of Tuberculosis Multidrug Resistance
Abstract
Background: The financing burden for tuberculosis treatment is increasing along with the increasing number of cases of Multidrug Resistant Tuberculosis (MDR-TB). The main problems that arise in MDR-TB patients are difficult and expensive treatment, high mortality rates and the potential to transmit resistant bacilli to others. The purpose of the study was to estimate the magnitude of the influence of smoking behavior and poverty on the incidence of MDR-TB.
Subjects and Method: This was a meta-analysis with PICO, population: active patients on TB treatment. Intervention: Smoking behavior and poverty. Comparison: not smoking and not poor. Result: MDR TB. The articles used in this study were obtained from three databases, namely Google Scholar, Pubmed, and Science Direct. Keywords to search for articles are “poverty” OR “smoking” AND “multidrug resistant tuberculosis”. Articles included are full-text English from 2012 to 2022. Articles were selected using a PRISMA flow diagram. Articles were analyzed using the Review Manager 5.3 application.
Results: A total of 12 articles came from the continents of Asia (China India, Indonesia), Africa (Sudan, Ethiopia, Tanzania), North America (Georgia), and South America (Peru). The results of this meta-analysis showed that smoking increased the risk of MDR TB 1.94 times compared to those who did not smoke (aOR = 1.94; 95% CI = 1.64 to 2.30; p = 0.005), and poverty increased the risk of MDR TB 1.85 times compared to those who did not. not in poverty (aOR= 1.85; 95% CI= 1.35 to 2.53; p= 0.004), and both results were statistically significant.
Conclusion: Smoking behavior and poverty increase the risk of MDR TB.
Keywords: smoking behavior, poverty, MDR TB.
Correspondence:
Bibit Irawan. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java, Indonesia. Email: irawanbibit@gmail.com. Mobile: +6293111570225.
Journal of Health Promotion and Behavior (2022), 07(04): 284-298
DOI: https://doi.org/10.26911/thejhpb.2022.07.04.02
References
Ali MH, Alrasheedy AA, Hassali MA, Kibuule D, Godman B (2019). Predictors of multidrug-resistant tuberculosis (MDR-TB) in Sudan. Antibiotics, 8(3): 1-11 doi: 10.3390/antibiotics-8030090.
Cheng Q, Xie L, Wang L, Lu M, Lu M, Li C, Wu Y et al. (2021). Incidence density and predictors of multidrug-resistant tuberculosis among individuals with previous tuberculosis history: a 15-year retrospective cohort study, Public Health Front. 9(5):1-14.
doi: 10.3389/FPUBH.2021.644347.
Evamawanti R (2021). Faktor Risiko Multi-drug Resistant Tuberculosis (MDR Tb) di Kabupaten Jember. Jember: Universitas Jember.
Kemenkes RI (2018). Kebijakan Program Penanggulangan Tuberculosis (Tuber-culosis Control Program Policies). Jakarta. Diakses pada: 12 Februari 2022.
Leveri TH, Lekule I, Mollel E, Lyamuyu F, Kilonzo K (2019). Predictors of Treatment Outcomes among Multidrug Resistant Tuberculosis Patients in Tanzania. Tuberc Res Treat 20(19): 356-366. doi: 10.1155/2019/3569018.
Li XX, Lu W, Zu RQ, Zhu LM, Yang HT, Cheng C, Shen T, et al. (2015). Comparing risk factors for primary multidrug-resistant tuberculosis and primary drug-susceptible tuberculosis in Jiangsu Province, china: A matched-pairs case-control study, AJTHAB. 92(2): 280–285. doi: 10.4269/ajtmh.13-0717.
Mahfuzhah I (2014). Gambaran faktor risiko penderita TB paru berdasarkan status gizi dan pendidikan di RSUD Dokter Soedarso (Description of risk factors for pulmonary TB patients based on nutritional status and ed¬ucation at RSUD Soedarso). 1(1):1-13.
Murti B (2018). Prinsip dan Metode Riset Epidemiologi (5th ed)( Principles and Methods of Epidemiological Research (5th ed). Surakarta: Program Studi Ilmu Kesehatan Masyarakat, Program Pascasarjana, Universitas Sebelas Maret.
Salindri AD, Kipiani M, Kempker RR, Gandhi NR, Darchia L, Tukvadze, Blumberg H, et al. (2016). Diabetes reduces the rate of sputum culture conversion in patients with newly diagnosed multidrug-resistant tuberculosis, Open Forum Infect. Dis. 3(3): 1-10. doi: 10.1093/OFID/OFW126.
Selamawit H, Girmay M, Belaineh G, Mulu-ken M, Alemayehu M, Pedro S, Gobena A (2013). Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study, BMC Public Health, 13(4):1–9. doi: /10.1186/1471-2458-13-782.
Semunigus T, Tessema B, Eshetle S, Moges F (2016). Smear positive pulmonary tuberculosis and associated factors among homeless individuals in Dessie and Debre Birhan towns, Northeast Ethiopia, Ann. clin. microbiol. 15(1): 50-58. doi: 10.1186/S12941-016-0165-X.
Sharma P, Lalwani J, Pandey P, Thakur A (2019). Factors associated with the development of secondary multidrug-resistant tuberculosis, Int. J. Prev. Med. 10(1) : 60-67.doi:10.4103/ij-pvm.ijpvm_298_17.
Tao NN, Li YF, Song WM, Liu JY, Zhang QY, Xu TT, et al. (2021). Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: A retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019, BMJ Open, 11(6): 1-9. doi: 10.1136/bmjopen-2020-044349.
Thapa B, Paudel R, Thapa P, Shrestha A, Poudyal AK (2015). Prevalence of Diabetes among Tuberculosis Patients and Associated Risk Factors in Kath-mandu Valley. Int. J. Tuberc. Lung Dis. 12(2): 20-27 doi: 10.3126/saarctb.v12i2.15951
Tola HH, Shojaeizadeh D, Gamaroudi G, Tol A, Yekaninejad MS, Ejeta LT, Kebede A, et al. (2015). Psychological distress and its effect on tuberculosis treatment outcomes in Ethiopia. Glob. Health Action, 8(1): 1-11 doi: 10.34-02/GHA.V8.29019.
Viswanathan V, Kumpatla S, Aravinda-lochanan V, Rajan R, Chinnasamy C, Srinivasan R, Selvam JM (2012). Prevalence of Diabetes and Pre-Diabetes and Associated Risk Factors among Tuberculosis Patients in India, PLoS ONE. 7(7): 1-8. doi: 10.1371/-journal.pone.0041367.
Welekidan LN, Skjerve E, Dejene TA, Gebremichael W, Brynildsrud O, Agdestein A, Tessema GT, et al. (2020). Characteristics of pulmonary multi-drug resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study. PLoS ONE, 15(8):1–20.doi:10.1371/journal.pone.0236362
Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoyo R, Lonnroth K et al. (2014). Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with Multi-Drug Resistance: A Prospective Cohort Study, Peru. PLoS Med. 11(7): 1-17 doi: 10.1371/JOURNAL.PMED.-1001675.
Workie MG, Aycheh MW, Birhanu MY, Tsegaye TB, et al. (2021). Treatment Interruption Among Drug-Susceptible Pulmonary Tuberculosis Patients in Southern Ethiopia. Patient Prefer. Adherence. 15(1): 1143–1151. doi: 10.-2147/PPA.S307091.
Zhang C, Wang Y, Shi G, Han W, Zhang H, Xi X, et al. (2016). Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study. BMC Public Health, 16(1): 1-8. doi: 10.1186/S12889-016-2711-Z.
Zhao P, Li X, Zhang SF, Wang XS, Liu CY (2012). Social behaviour risk factors for drug resistant tuberculosis in mainland china: A meta-analysis. Int J Med Res. 40(2): 436–445. doi: 10.-1177/147323001204000205
